Progress in medical practice is often the result of a redefinition of pathologies and therapeutic targets. This is a natural translation of advances made in the pathophysiologic understanding of disease and clinical entities. In this manner, the use of biological agents is entering the field of cardiovascular medicine. This selective review of the literature summarizes certain studies published this year in the areas of internal, cardiovascular, pulmonary and thrombotic medicine.